did not achieve significancep = 0.11
For patients with progression of disease within 24 months, FLIPI-L was more predictive of PFS, with estimated median event-free survival of 14.75, 12.55, and 10.0 months for FLIPI-L low, intermediate, and high, respectively ( p = 0.05), while the FLIPI did not achieve significance ( p = 0.11).